[Fungal infections in the COVID-19 pandemic, the case of mucormycosis]
- PMID: 34579807
- PMCID: PMC8461762
- DOI: 10.1016/j.ram.2021.09.001
[Fungal infections in the COVID-19 pandemic, the case of mucormycosis]
References
-
- Fernández N.B., Davel G. Micosis de declaración obligatoria: utopía o realidad Una cuestión olvidada por resolver. Rev Argent Microbiol. 2019;51:101–102. https://doi.org/10.1016/j.ram.2019.04.001. - PubMed
-
- Jeong W., Keighley C., Wolfe R., Lee W.L., Slavin M.A., Kong D.C.M., Chen S.C.A. The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26–34. https://doi.org/10.1016/j.cmi.2018.07.011. - PubMed
-
- Patel A., Agarwal R., Rudramurthy S.M., Shevkani M., Xess I., Sharma R. MucoCovi Network. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India. Emerg Infect Dis. 2021 Jun 4;27(9.) https://doi.org/10.3201/eid2709.210934. - PMC - PubMed
-
- Prakash H., Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021;9:523. https://doi.org/10.3390/microorganisms9030523. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical